Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,673,890 | 1,442,291 | 2,319,702 | 2,794,793 | 2,177,224 |
| Marketable Securities | 110,775 | N/A | 28,181 | 91,188 | 20,180 |
| Receivables | 4,452,564 | 5,253,542 | 4,369,885 | 3,951,778 | 4,066,200 |
| Inventories | 2,630,389 | 2,549,450 | 2,644,386 | 2,608,841 | 2,579,627 |
| Other current assets | 2 | 88,323 | 0 | 0 | 1 |
| TOTAL | $10,867,620 | $9,333,606 | $9,362,154 | $9,446,600 | $8,843,232 |
| Non-Current Assets | |||||
| PPE Net | 7,459,146 | 7,512,465 | 7,577,595 | 7,494,700 | 7,259,522 |
| Investments And Advances | 273,245 | 254,783 | 271,019 | 307,238 | 315,959 |
| Intangibles | 854,445 | 862,273 | 874,667 | 749,917 | 888,540 |
| Other Non-Current Assets | 650,618 | 684,886 | 743,803 | 612,837 | 449,842 |
| TOTAL | $9,237,453 | $9,314,406 | $9,467,084 | $9,164,692 | $8,913,863 |
| Total Assets | $20,105,070 | $18,648,010 | $18,829,240 | $18,611,290 | $17,757,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 207,962 | 183,739 | 220,953 | 210,984 | 189,003 |
| Accounts payable and accrued liabilities | 1,323,540 | 789,309 | 953,064 | 878,206 | 793,511 |
| Other current liabilities | 7,831,350 | 7,881,125 | 7,036,156 | 7,326,777 | 6,903,956 |
| TOTAL | $9,937,847 | $9,332,720 | $8,841,552 | $9,399,963 | $8,523,207 |
| Non-Current Liabilities | |||||
| Long Term Debt | 403,960 | 423,308 | 451,049 | 436,123 | 448,336 |
| Other Non-Current Liabilities | 858,137 | 849,127 | 891,455 | 856,899 | 709,326 |
| TOTAL | $1,297,249 | $1,280,559 | $1,354,496 | $1,321,332 | $1,239,287 |
| Total Liabilities | $11,235,100 | $10,613,280 | $10,196,050 | $10,721,290 | $9,762,494 |
| Shareholders' Equity | |||||
| Common Shares | 69,419 | 70,896 | 71,952 | 71,520 | 72,288 |
| Retained earnings | 8,864,067 | 8,101,936 | 8,666,769 | 8,004,429 | 8,065,835 |
| Other shareholders' equity | -63,510 | -136,100 | -104,531 | -184,952 | -142,522 |
| TOTAL | $8,869,976 | $8,034,732 | $8,633,190 | $7,889,997 | $7,994,601 |
| Total Liabilities And Equity | $20,105,076 | $18,648,012 | $18,829,240 | $18,611,287 | $17,757,095 |